Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.17)
%-6.37
Latest2.50
High2.62
Low2.44
Volume258,871
Turnover (SEK)646,062
Market Cap (MSEK)134

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:20 PMLFBAVA2.501,000
5:20 PMNRDAVA2.5011
5:20 PMNRDAVA2.501,600
5:20 PMMLIAVA2.513,724
5:20 PMAVAAVA2.512,000
5:20 PMNRDAVA2.53700
5:20 PMAVANON2.531,000
4:37 PMNONAVA2.5629
4:29 PMNONAVA2.561
4:25 PMNONAVA2.563,700

Scheduled Reports

DateReport
2017-11-10Extra bolagsstämma
2017-11-18Delårsrapport ett
2017-12-14Årsstämma




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se